Boston, MA, United States of America

Paraskevi Evi Kolovou

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Paraskevi Evi Kolovou

Introduction

Paraskevi Evi Kolovou is a notable inventor based in Boston, MA (US). She has made significant contributions to the field of ocular medicine, particularly through her innovative patents. With a total of 2 patents, her work focuses on advancing treatments for ocular diseases.

Latest Patents

Kolovou's latest patents revolve around the use of ABCB5(+) stem cells for treating ocular diseases. These patents detail various methods for treating subjects with ocular conditions, isolating ocular stem cells, and producing ocular grafts for transplantation. Additionally, her inventions promote ocular cell regeneration and include grafts and preparations containing isolated ocular stem cells characterized by the expression of ABCB5 on their cell surface.

Career Highlights

Throughout her career, Kolovou has worked with esteemed organizations such as the Schepens Eye Research Institute and Children's Medical Center Corporation. Her experience in these institutions has allowed her to collaborate with leading experts in the field, enhancing her research and innovation capabilities.

Collaborations

Some of her notable coworkers include Markus H. Frank and Natasha Y. Frank, who have contributed to her research endeavors. Their collaboration has furthered the understanding and treatment of ocular conditions.

Conclusion

Paraskevi Evi Kolovou's contributions to ocular medicine through her patents and collaborations highlight her dedication to innovation in the field. Her work continues to pave the way for advancements in treating ocular diseases, showcasing the impact of her research on improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…